A 2025 analysis1 of NIH medical records found that 10.3% of males on feminizing hormone therapy developed kidney stones, compared to 4.8% of those not on hormones. The risk was especially elevated for those on both estrogen and antiandrogens, with odds more than 2.5 times higher. The post Males on feminizing hormones face over double the risk of kidney stones. appeared first on Stats for Gender.| Stats for Gender
A 2025 Swiss follow‑up study1 (mean 27.5 years post‑surgery) found prolapse rates highest among those with peritoneal vaginoplasty (83%), followed by penile‑inversion techniques (17%) and intestinal vaginoplasty (14%). Surgical repairs often reduced symptoms but highlight long‑term complications rarely discussed before transition.| Stats for Gender
More than a third of UK residents in a 2023 survey1 by Murray Blackburn Mackenzie—a Scottish independent policy analysis collective—did not know that “transgender women” are natal males. The findings show significant misunderstanding of the term and emphasize the need for clearer language in policy and media communication. The post More than a third of UK residents in a survey did not know that “transgender women” are male. appeared first on Stats for Gender.| Stats for Gender
Based on a 2019 review, genital surgery as part of medical transition is generally less common than chest surgery, with reported rates of 25–50% for transmen (natal females) and 5–10% for transwomen (natal males). These estimates come from a range of surveys and clinical reports.| Stats for Gender
A 2025 review summarizes wide-ranging risks tied to estrogen use in trans-identified males: The review emphasizes that many of these risks are under-recognized in clinical practice, raising urgent concerns about safety and informed consent. The post Estrogen use in trans-identified males is associated with a wide range of serious health risks—including blood clots, stroke, cancer, infertility, and cognitive decline. appeared first on Stats for Gender.| Stats for Gender
A study by Abern et al. surveyed 996 trans-identified adults and found that 50% of females reported experiencing sexual assault, compared to 37% of males. The post Trans-identified females report higher rates of sexual assault than their male counterparts. appeared first on Stats for Gender.| Stats for Gender
A single dose of Spinogenix’s investigational oral therapy SPG601 led to significant reductions in a measure of abnormal brain activity among men with fragile X syndrome, according to top-line results from a Phase 2a trial. Announced by Spinogenix in a company press release, the results from the placebo-controlled Phase 2a trial (NCT06413537) were also presented […] The post SPG601 found to reduce measure of abnormal brain activity in fragile X appeared first on Fragile X News Today.| Fragile X News Today – The Web's Daily Resource for Fragile X News
Sensory symptoms, including overreactions to stimuli, are very common among fragile X patients and affect their daily life, a study found.| Fragile X News Today